Literature DB >> 18006073

Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.

Andrew A Nierenberg1, Jonathan E Alpert, Bradley N Gaynes, Diane Warden, Stephen R Wisniewski, Melanie M Biggs, Madhukar H Trivedi, Jennifer L Barkin, A John Rush.   

Abstract

BACKGROUND: Clinicians routinely ask patients with non-psychotic major depressive disorder (MDD) about their family history of suicide. It is unknown, however, whether patients with a family member who committed suicide differ from those without such a history.
METHODS: Patients were recruited for the STAR*D multicenter trial. At baseline, patients were asked to report first-degree relatives who had died from suicide. Differences in demographic and clinical features for patients with and without a family history of suicide were assessed.
RESULTS: Patients with a family history of suicide (n=142/4001; 3.5%) were more likely to have a family history of MDD, bipolar disorder, or any mood disorder, and familial substance abuse disorder, but not suicidal thoughts as compared to those without such a history. The group with familial suicide had a more pessimistic view of the future and an earlier age of onset of MDD. No other meaningful differences were found in depressive symptoms, severity, recurrence, depressive subtype, or daily function.
CONCLUSIONS: A history of completed suicide in a family member was associated with minimal clinical differences in the cross-sectional presentation of outpatients with MDD. Limitations of the study include lack of information about family members who had attempted suicide and the age of the probands when their family member died. STAR*D assessments were limited to those needed to ascertain diagnosis and treatment response and did not include a broader range of psychological measures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18006073      PMCID: PMC5886723          DOI: 10.1016/j.jad.2007.10.011

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  25 in total

1.  Computerized assessment of depression and anxiety over the telephone using interactive voice response.

Authors:  K A Kobak; J H Greist; J W Jefferson; J C Mundt; D J Katzelnick
Journal:  MD Comput       Date:  1999 May-Jun

2.  Suicide risk in relation to family history of completed suicide and psychiatric disorders: a nested case-control study based on longitudinal registers.

Authors:  Ping Qin; Esben Agerbo; Preben Bo Mortensen
Journal:  Lancet       Date:  2002-10-12       Impact factor: 79.321

3.  A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire.

Authors:  M Zimmerman; J I Mattia
Journal:  Arch Gen Psychiatry       Date:  2001-08

4.  Suicide risk in relation to socioeconomic, demographic, psychiatric, and familial factors: a national register-based study of all suicides in Denmark, 1981-1997.

Authors:  Ping Qin; Esben Agerbo; Preben Bo Mortensen
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

5.  Prolactin response to D-fenfluramine and suicidal behavior in depressed patients.

Authors:  H Corrêa; F Duval; M Mokrani; P Bailey; F Trémeau; L Staner; T S Diep; Y Hodé; M A Crocq; J P Macher
Journal:  Psychiatry Res       Date:  2000-04-10       Impact factor: 3.222

6.  Family history of suicide.

Authors:  A Roy
Journal:  Arch Gen Psychiatry       Date:  1983-09

Review 7.  Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies.

Authors:  M Asberg
Journal:  Ann N Y Acad Sci       Date:  1997-12-29       Impact factor: 5.691

8.  Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

Authors:  A John Rush; Maurizio Fava; Stephen R Wisniewski; Philip W Lavori; Madhukar H Trivedi; Harold A Sackeim; Michael E Thase; Andrew A Nierenberg; Frederic M Quitkin; T Michael Kashner; David J Kupfer; Jerrold F Rosenbaum; Jonathan Alpert; Jonathan W Stewart; Patrick J McGrath; Melanie M Biggs; Kathy Shores-Wilson; Barry D Lebowitz; Louise Ritz; George Niederehe
Journal:  Control Clin Trials       Date:  2004-02

9.  Familial pathways to early-onset suicide attempt: risk for suicidal behavior in offspring of mood-disordered suicide attempters.

Authors:  David A Brent; Maria Oquendo; Boris Birmaher; Laurence Greenhill; David Kolko; Barbara Stanley; Jamie Zelazny; Beth Brodsky; Jeffrey Bridge; Steve Ellis; J Octavio Salazar; J John Mann
Journal:  Arch Gen Psychiatry       Date:  2002-09

10.  Family history of suicide among suicide victims.

Authors:  Bo Runeson; Marie Asberg
Journal:  Am J Psychiatry       Date:  2003-08       Impact factor: 18.112

View more
  5 in total

Review 1.  Endophenotypes as a measure of suicidality.

Authors:  Dimitry A Chistiakov; Zurab I Kekelidze; Vladimir P Chekhonin
Journal:  J Appl Genet       Date:  2012-09-02       Impact factor: 3.240

2.  STAR*D: revising conventional wisdom.

Authors:  A John Rush; Diane Warden; Stephen R Wisniewski; Maurizio Fava; Madhukar H Trivedi; Bradley N Gaynes; Andrew A Nierenberg
Journal:  CNS Drugs       Date:  2009-08       Impact factor: 5.749

3.  Association between familial suicidal behavior and frequency of attempts among depressed suicide attempters.

Authors:  D Lizardi; L Sher; G M Sullivan; B Stanley; A Burke; M A Oquendo
Journal:  Acta Psychiatr Scand       Date:  2009-05       Impact factor: 6.392

4.  A 2-year psychological autopsy study of completed suicides in the athens greater area, Greece.

Authors:  Antonios Paraschakis; Ioannis Michopoulos; Christos Christodoulou; Filippos Koutsaftis; Lefteris Lykouras; Athanassios Douzenis
Journal:  Psychiatry Investig       Date:  2015-01-20       Impact factor: 2.505

Review 5.  Vagus Nerve Stimulation (VNS) and Other Augmentation Strategies for Therapy-Resistant Depression (TRD): Review of the Evidence and Clinical Advice for Use.

Authors:  Helge H O Müller; Sebastian Moeller; Caroline Lücke; Alexandra P Lam; Niclas Braun; Alexandra Philipsen
Journal:  Front Neurosci       Date:  2018-04-10       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.